introduction hypertension systolic blood pressure greater and/or diastolic pressure greater subject taking antihypertensive medication every year raised blood pressure kill nine million people prevalence hypertension range developed country almost two-thirds patient untreated poorly controlled hypertension systematic meta-analysis ethiopia showed prevalence hypertension 19.6 generally non-communicable disease ncds major cause death world ncds accounted million million death high blood pressure major risk factor cardiovascular disease chronic kidney disease leading cause mortality world-wide endothelial dysfunction hypertensive patient manifested increased level vascular cell adhesion molecule-1 svcam-1 soluble intercellular adhesion molecule-1 sicam-1 von willebrand factor vwf mediating vessel injury hypertension lead high level circulating pro-inflammatory cytokine pro-inflammatory cytokine tumor necrosis factor interleukin-6 direct inhibitory effect bone marrow may cause anemia hypertensive patient hypertension also strongly affect functional physicochemical property red blood cell rbc study shown circulating rbc might impaired hypertensive patient due alteration sodium–lithium counter-transport sodium–potassium atpase activity rbc membrane rbc deformability decrease due sodium–potassium atpase activity rbc membrane impairment anemia risk factor adverse cardiovascular disease outcome hypertension low hemoglobin level associated high risk coronary heart disease chronic anemia increase preload reduces afterload lead increased cardiac output hypertension patient long term may result maladaptive left ventricular hypertrophy turn well-recognized risk factor cardiovascular disease outcome all-cause mortality hypertension recently low hemoglobin hematocrit level strongly indicate hypertensive end-organ damage specifically kidney failure hypertensive patient however limited information concerning prevalence anemia among hypertensive patient ethiopia therefore study aimed ass prevalence anemia associated factor among hypertensive patient amhara regional state method material study setting period institution-based cross-sectional study conducted selected referral hospital amhara regional state february april study population adult hypertensive patient follow-up university gondar comprehensive specialized felege hiwot referral hospital included study patient diabetic mellitus chronic kidney disease human immunodeficiency virus infection hematological malignancy excluded study sample size calculation sampling procedure sample size calculated using single population proportion formula based estimate anemia prevalence confidence interval marginal error 1.96 0.5\left 0.5 0.05 sample size estimated prevalence value margin sampling error tolerated α/2 1.96 critical value confidence interval certainty adding non-response rate total participant selected sampling procedure five referral hospital amhara region data collection period university gondar comprehensive specialized felege hiwot referral hospital selected using lottery method simple random sampling technique three hundred fifty four hundred fifty hypertensive patient encountered follow-up clinic university gondar comprehensive specialized felege hiwot referral hospital respectively time data collection period using systematic random sampling technique htn patient selected university gondar comprehensive specialized felege hiwot referral hospital respectively value first patient chosen lottery system first patient interviewed fig figure flow chart describes proportion patient taking university gondar comprehensive specialized felege hiwot referral hospital full size image research carried accordance helsinki declaration standard university gondar institutional review board provided ethical clearance study participant signed written informed consent data collection began study participant unable read write parent legally authorized representative signed written informed consent behalf privacy confidentiality study participant data also carefully maintained operational definition hypertension systolic blood pressure mmhg and/or diastolic blood pressure mmhg taking antihypertensive medication anemia hemoglobin level gm/dl men gm/dl woman age year old recommended world health organization female participant blood hemoglobin level 11–11.9 gm/dl 8–10.9 gm/dl gm/dl mild moderate severe anemia respectively whereas male participant blood hemoglobin level 11–12.9 gm/dl 8–10.9 gm/dl gm/dl mild moderate severe anemia respectively impaired glomerular filtration rate patient estimated glomerular filtration rate egfr ml/min/1.73 using epi equation participant blood pressure 130/80 mmhg least three consecutive follow-up measurement considered controlled blood pressure participant body mass index bmi 18.5 kg/m 18.5–24.9 kg/m 25–29.9 kg/m classified underweight normal overweight respectively bmi kg/m classified obesity data collection procedure tool data collected using interviewer-administered structured questionnaire included socio-demographic information medical card review weight height assessment aside face-to-face interview follow-up blood pressure record patient card examined estimated glomerular filtration rate calculated using ckd-epi creatinine equation currently recommended predicting gfr adult older recent creatinine hemoglobin level recorded medical record within one month prior time data collection taken digital automatic blood pressure monitor used take blood pressure reading body weight height determined using height measurement stand weighing machine participant blood pressure height weight assessed according established protocol using world health organization protocol data processing analysis data collected checked completeness entered coded epi data version 3.0 exported stata analysis continuous variable presented using mean standard deviation categorical variable like frequency pie chart used researcher used bivariable multivariable logistic regression analysis variable associated anemia p-value 0.25 using bi-variable logistic regression included multivariable regression model finally factor p-value 0.05 multivariable logistic regression validated significantly associated anemia using percent confidence interval hosmer lemeshow goodness test done evaluate model fitness value 0.245 data quality assurance assure data quality training given principal investigator data collector regard questioner method data extraction patient chart four bsc nurse working chronic follow ward participated data collection process questionnaire translated amharic language expert retranslated back english another expert consistency questionnaire pretest conducted tibebe ghion specialized hospital questionnaire amended accordingly data collector supervised supervisor principal investigator data collection period prevent coronavirus disease covid-19 transmission data collector collect data applying recommended covid-19 prevention mechanism result sociodemographic characteristic study participant total hypertensive patient participated study 99.5 respond survey majority study participant 67.1 male sex 81.9 married urban dweller 38.7 attained primary school table mean age body mass index study participant 52.5 16.8 year 21.9 2.7 kg/m respectively table socio-demographic characteristic study participant associated factor among hypertensive patient gondar comphrensive specialized felege hiwot referral hospital full size table clinical factor study participant patient living disease year mean creatinine 1.1 mg/dl majority patient 60.3 controlled blood pressure mean systolic diastolic blood pressure study participant 10.9 mg/dl 74.9 7.7 mmhg respectively table table clinical characteristic study participant among hypertensive patient university gondar comprehensive specialized felege hiwot referral hospital full size table prevalence anemia among hypertensive patient mean hemoglobin level study participant 12.7 gm/dl 1.5 prevalence anemia 17.6 14.3 -21.5 among hypertensive patient among anemic hypertensive patient majority hypertensive patient mild anemia 51.2 fig figure prevalence anemia among hypertensive patient university gondar comprehensive specialized felege hiwot referral hospital full size image factor associated anemia among hypertensive patient bivariable logistic regression estimated glomerular filtration age income level marital status duration disease educational level blood pressure status pulse pressure variable associated anemia value 0.25 multivariable logistic regression estimated glomerular filtration rate duration disease blood pressure status pulse pressure variable associated anemia patient uncontrolled blood pressure 1.91 aor 1.91 1.08–3.35 time likely develop anemia compared patient controlled blood pressure one-unit increase pulse pressure study participant led 1.05 fold aor 1.05 1.02–1.08 increase odds developing anemia odds anemia 2.37 aor 2.37 1.36–4.15 time higher patient living disease year compared year hypertensive patient egfr ml/min 2.77 time aor 2.77 1.56–4.92 likely develop anemia patient egfr ml/min table table factor associated anemia among hypertensive patient university gondar comprehensive specialized felege hiwot referral hospital full size table discussion hypertension major health problem worldwide associated increased risk cardiovascular disease even though hypertension impact red blood cell increase risk cardiovascular complication scarcity data pertaining prevalence anemia among hypertensive patient therefore fill gap study aimed determine prevalence anemia associated factor among hypertensive patient prevalence anemia 17.6 14.3–21.5 among hypertensive patient result similar study conducted australia study done usa might due sociodemographic difference mean age study participant lower age increase probability anemic increased pathophysiology anemia hypertensive patient explained variety way patient suffering essential hypertension showed decreased deformability red blood cell rbc hypertensive patient high intracellular concentration sodium red blood cell due impaired na–k atpase activity hypertensive patient hypertensive erythrocyte demonstrate membrane lipid peroxidation reduced anti-oxidative enzyme activity expose cell membrane oxidative stress therefore factor exposed hypertensive patient rbc hemolytic anemia endothelial dysfunction another common phenomenon hypertension promotes production pro-inflammatory cytokine lead suppression erythropoiesis resistance bone marrow erythropoietin stimulation high level circulatory inflammatory cytokine tumor necrosis factor interleukin-6 direct inhibitory effect iron absorption gut iron release store cell via hepcidin-mediated pathway resulting anemia majority study found link antihypertensive medication anemia angiotensin-converting enzyme inhibitor angiotensin receptor blocker antihypertensive medication commonly affect erythropoiesis process patient uncontrolled blood pressure 1.91 time likely develop anemia compared patient controlled blood pressure finding line study blood pressure increase increment blood viscosity decrease red blood cell rbc deformability formation rbc rouleau rbc aggregate might result hemolysis red blood cell one-unit increase hypertensive patient pulse pressure resulted 1.1 fold increase odds developing anemia consistent study study showed high level mmhg strongly associated arterial stiffness act independent risk factor cardiovascular complication suggests necessity close monitoring anemia treatment cardiovascular mortality significantly regularly increase increasing mechanism relationship anemia remains unclear however previous study show anemia positively associated high associated positively systolic blood pressure sbp inversely associated diastolic blood pressure dbp anemia also positively associated arterial stiffness arterial stiffness common presentation pulse pressure increase one reason sbp increased decrease hemoglobin hemoglobin dbp decreased reduction hemoglobin hematocrit odds anemia 2.37 time patient living disease year compared year line another study hypertensive patient egfr ml/min 2.77 time likely develop anemia patient egfr ml/min impaired glomerular filtration rate might associated anemia due decreasing erythropoietin synthesis kidney study showed essential hypertension mild renal insufficiency might linked anemia renal impairment lead anemia though compromised production erythropoietin peritubular fibroblast kidney glomerular filtration rate decrease renin angiotensin aldosterone system activated increase blood volume thereby cause haemodilution anemia hypertensive patient low hemoglobin level associated increased morbidity mortality hypertensive patient general hypertensive patient microcirculation worsened hypertensive complication increased due decreased red cell deformability red blood cell membrane damage finding study useful better treatment respect minimizing risk complication developing hypertensive patient result hypertensive patient hemoglobin level checked regular basis avoid end-organ damage limitation study investigation glomerular filtration rate could influenced temporary change creatinine level caused variety variable ruled single serum creatinine level medical record used compute patient egfr since secondary data used level hemoglobin creatinine might affect reliability data morphology red blood cell included study recommended researcher study stronger study design explore cause-and-effect relationship anemia hypertension conclusion nearly one five hypertensive patient anemia patient mild anemia impaired estimated glomerular filtration rate duration htn blood pressure status pulse pressure independent predictor anemia among hypertensive patient recommended hypertensive patient hemoglobin level checked regular interval order receive appropriate treatment prevent hypertension-related complication